On April 3, 2003, Wall, Michael G.; Conroy, Peter J. published a patent.Application of 86393-32-0 The title of the patent was Method of treating middle ear infections. And the patent contained the following:
Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane. The experimental process involved the reaction of 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate(cas: 86393-32-0).Application of 86393-32-0
The Article related to eardrum perforation middle ear infection dexamethasone ciprofloxacin, Pharmaceuticals: Formulation and Compounding and other aspects.Application of 86393-32-0
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics